Nalaganje...
Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis
An understanding of the risks, benefits, and relative value of glatiramer acetate (GA) in multiple sclerosis (MS) has been evolving based on recently completed head-to-head studies: REGARD (REbif vs Glatiramer Acetate in Relapsing MS Disease); BEYOND (Betaseron Efficacy Yielding Outcomes of a New Do...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2010
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2857614/ https://ncbi.nlm.nih.gov/pubmed/20421914 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|